Published in Am J Hematol on October 01, 2000
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) (1976) 3.07
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest (1980) 2.58
Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum (1986) 2.39
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest (1996) 2.39
Incomplete Reiter's syndrome: discriminating features and HL-A W27 in diagnosis. Ann Intern Med (1976) 2.34
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) (1985) 2.01
Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum (1990) 1.99
The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood (1986) 1.98
Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum (1981) 1.97
Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum (2001) 1.87
Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci U S A (1992) 1.81
Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford) (2006) 1.77
Evidence that autoimmunity in man is a Mendelian dominant trait. Am J Hum Genet (1986) 1.74
Studies in familial systemic lupus erythematosus. Medicine (Baltimore) (1976) 1.70
Immune interferon and leukocyte-conditioned medium induce normal and leukemic myeloid cells to differentiate along the monocytic pathway. J Exp Med (1983) 1.69
Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med (1983) 1.68
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis. Rheumatology (Oxford) (2007) 1.63
Lupus anticoagulants. Prog Hemost Thromb (1982) 1.56
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Genetic factors predisposing to autoimmune diseases. Autoimmune hemolytic anemia, chronic thrombocytopenic purpura, and systemic lupus erythematosus. Am J Med (1982) 1.51
Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science (1986) 1.50
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum (1988) 1.47
Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum (1999) 1.45
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Complement component C4A and C4B levels in systemic lupus erythematosus: quantitation in relation to C4 null status and disease activity. J Rheumatol (1993) 1.42
Role of endothelium in thrombosis and hemostasis. Annu Rev Med (1996) 1.42
Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med (1991) 1.40
A monoclonal antibody to human platelet glycoprotein IIIa detects a related protein in cultured human endothelial cells. J Clin Invest (1985) 1.38
Incomplete Reiter's syndrome: clinical comparisons with classical triad. Ann Rheum Dis (1979) 1.34
Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J Clin Invest (1989) 1.33
Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med (1986) 1.31
Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine (Baltimore) (1984) 1.30
Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med (1985) 1.28
Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum (1982) 1.27
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation (2000) 1.17
Adhesion of platelets to surface-bound fibrinogen under flow. Blood (1996) 1.15
HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). Tissue Antigens (1999) 1.14
Revised criteria for the classification of rheumatoid arthritis. Bull Rheum Dis (1989) 1.14
HL-A 27 in Reiter's syndrome and psoriatic arthritis: a genetic factor in disease susceptibility and expression. J Rheumatol (1984) 1.13
Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood (1987) 1.12
Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med (1990) 1.12
HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis. Hum Immunol (1981) 1.11
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med (1984) 1.11
Systemic sclerosis (scleroderma): specific autoantigen genes are selectively overexpressed in scleroderma fibroblasts. J Immunol (2001) 1.11
Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. J Immunol (1991) 1.11
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest (1992) 1.11
The genetics of lupus. Curr Opin Rheumatol (1998) 1.10
Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies. Arthritis Rheum (1983) 1.08
The coexistence of rheumatoid arthritis with Reiter's syndrome and/or ankylosing spondylitis: a model of dual HLA-associated disease susceptibility and expression. J Rheumatol (1981) 1.08
Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum (1996) 1.08
Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases. J Immunol (1999) 1.07
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians. Ann Rheum Dis (2009) 1.06
Multiplicity of antibodies in myositis sera. Arthritis Rheum (1984) 1.05
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med (1986) 1.05
Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus. Immunogenetics (1985) 1.04
Family studies in HLA-B27 associated arthritis. Medicine (Baltimore) (1978) 1.04
Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. Arthritis Rheum (1984) 1.04
Palmar fasciitis and arthritis with malignant neoplasms: a paraneoplastic syndrome. Semin Arthritis Rheum (1986) 1.03
Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol (1989) 1.03
Site-directed mutagenesis of the arginine-glycine-aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem (1993) 1.03
Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis (2010) 1.02
Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol (1982) 1.02
Hypothyroidism presenting as a polymyositis-like syndrome. Report of two cases. Arthritis Rheum (1977) 1.01
Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am J Med (1992) 1.01
Seronegative spondylarthropathies. Bull Rheum Dis (1987) 1.00
The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol (1982) 0.99
P-selectin in arterial thrombosis. Z Kardiol (2004) 0.98
Familial occurrence of progressive systemic sclerosis and systemic lupus erythematosus. J Rheumatol (1984) 0.97
Microvesicle-associated tissue factor and Trousseau's syndrome. J Thromb Haemost (2007) 0.96
Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. J Rheumatol (1984) 0.96
Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis. Johns Hopkins Med J (1977) 0.96
Binding of recombinant fibrinogen mutants to platelets. J Biol Chem (1994) 0.96
SPARC, an upstream regulator of connective tissue growth factor in response to transforming growth factor beta stimulation. Arthritis Rheum (2006) 0.96
Procoagulant-tissue factor activity of circulating peripheral blood leukocytes. Results of in vivo studies. Thromb Res (1980) 0.96
HLA-D related (DR) antigens in various kinds of myositis. Hum Immunol (1981) 0.96
Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation (1999) 0.96
Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population. Arthritis Rheum (1998) 0.95
Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum (1984) 0.94
The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study. J Orthop Surg (Hong Kong) (2003) 0.94
Familial systemic lupus erythematosus: immunogenetic studies in eight families. Medicine (Baltimore) (1983) 0.93
Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum (1988) 0.93
Primary biliary cirrhosis in systrmic sclerosis (scleroderma) and polymyositis. Johns Hopkins Med J (1974) 0.93
Amyloidosis in Reiter's syndrome. J Rheumatol (1979) 0.92
Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus. Arthritis Rheum (1983) 0.92
Studies of immune functions of patients with systemic lupus erythematosus. Arthritis Rheum (1979) 0.92
Methotrexate therapy in polymyositis. Ann Rheum Dis (1973) 0.92
IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus. J Rheumatol (2000) 0.91
The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis. Arthritis Rheum (1996) 0.91
Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. Am J Epidemiol (1989) 0.91
Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations. Arthritis Rheum (2001) 0.91
Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. Arthritis Rheum (1993) 0.91
Juvenile-onset chronic arthritis. Clinical and roentgenographic features of a unique HLA-B27 subset. Am J Med (1980) 0.91
Immunogenetics of the neonatal lupus syndrome. Ann Intern Med (1983) 0.90
C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics (1989) 0.90
Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J Clin Invest (1989) 0.90
A new role for P-selectin in shear-induced platelet aggregation. Circulation (2000) 0.90
Role for sulfatides in platelet aggregation. Circulation (2001) 0.90